The European Medicines Agency (EMEA) will hold a workshop to review and discuss comments received on the draft guideline on first-time-in-man clinical trials on 12 June 2007.

 

The aim of the workshop is to consider together with key stakeholders from the European Commission, national competent authorities, pharmaceutical industry, patients’ and healthcare professionals’ organisations, academia and related learned societies – the feedback received in order to ensure the clarity and acceptability of the guideline before it is finalised, shortly after the workshop.

 

Use this registration form to express your interest and send to the EMEA before 30 April 2007.